A Multicenter, Open-Label Phase II Clinical Trial of Combined MEK Plus EGFR Inhibition for Chemotherapy-Refractory Advanced Pancreatic Adenocarcinoma

Por Ko, Andrew H., Bekaii-Saab, Tanios, Van Ziffle, Jessica, Mirzoeva, Olga M., Joseph, Nancy, Talasaz, AmirAli, Kuhn, Peter, Tempero, Margaret A., Collisson, Eric A., Kelley, R. Kate, Venook, Alan P., Dito, Elizabeth, Ong, Anna, Ziyeh, Sharvina, Courtin, Ryan, Linetskaya, Regina, Tahiri, Sanaa, Korn, W. Michael
Publicado no Clin Cancer Res (2015)

Radioembolization with (90)Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: final report of a...

Por Fidelman, Nicholas, Kerlan, Robert K., Hawkins, Randall A., Pampaloni, Miguel, Taylor, Andrew G., Kohi, Maureen P., Kolli, K. Pallav, Atreya, Chloe E., Bergsland, Emily K., Kelley, R. Kate, Ko, Andrew H., Korn, W. Michael, Van Loon, Katherine, McWhirter, Ryan M., Luan, Jennifer, Johanson, Curt, Venook, Alan P.
Publicado no J Gastrointest Oncol (2016)